跳至主要内容
临床试验/JPRN-UMIN000006621
JPRN-UMIN000006621已完成未知

Clinical evaluation of tafluprost and travoprost in Japanese patients with primary open angle glaucoma or ocular hypertension: multicenter, randomized, 12-week crossover study - Clinical evaluation of tafluprost and travoprost in glaucoma patients

Hiroshima uiversity0 个研究点目标入组 220 人开始时间: 2011年10月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patinets who with a history of allergy (i.e. hypersensitivity) to the drugs to be used during the study period. 2. Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential. 3. Patients who with a history of corneal refractive surgery. 4. Patinets who need wearing contact lenses during the study period. 5. Patinets who with extraocular disease, inflammation or infection in the eye(s) or eyelid(s). 6. Patinets who with a history of cataract surgery within 12 months. 7. Patinets who with a history of intraocular surgery including ocular laser treatment against glaucoma within 12 months 8. Patinets who has been treated with prostaglandin/timolol malate fixed combination. 9. Patinets who has been treated with prostaglandin generic drug. 10. Patinets who is treated dry eye therapy (drug medication, punctum plug and punctum occlusion). 11. Patinets who the investigator consider ineligible for enrolment

研究者

发起方
Hiroshima uiversity

相似试验